These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2889241)

  • 1. Pharmacology and structure-activity relationships of alpha 2-adrenoceptor antagonists.
    Clark RD; Michel AD; Whiting RL
    Prog Med Chem; 1986; 23():1-39. PubMed ID: 2889241
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.
    Ruffolo RR; Bondinell W; Hieble JP
    J Med Chem; 1995 Sep; 38(19):3681-716. PubMed ID: 7562902
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
    Timmermans PB; de Jonge A; Thoolen MJ; Wilffert B; Batink H; van Zwieten PA
    J Med Chem; 1984 Apr; 27(4):495-503. PubMed ID: 6142954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha adrenoceptor pharmacology.
    Tranquilli W; Thurmon JC
    J Am Vet Med Assoc; 1984 Jun; 184(11):1400-2. PubMed ID: 6145696
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological options in the treatment of benign prostatic hyperplasia.
    Kenny B; Ballard S; Blagg J; Fox D
    J Med Chem; 1997 Apr; 40(9):1293-315. PubMed ID: 9135028
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes.
    Ruffolo RR; Nichols AJ; Stadel JM; Hieble JP
    Annu Rev Pharmacol Toxicol; 1993; 33():243-79. PubMed ID: 8098595
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alpha-adrenoceptor antagonist (blocker)].
    Shigetomi S
    Nihon Rinsho; 1997 Aug; 55(8):2055-60. PubMed ID: 9284423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-adrenergic blockade in the treatment of essential hypertension.
    De Leeuw PW; Birkenhäger WH
    Neth J Med; 1983; 26(9):274-82. PubMed ID: 6140644
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
    Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the adrenergic receptor specificity of inhibitors of phenylethanolamine N-methyltransferase.
    Pendleton RG; Hieble JP
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):399-408. PubMed ID: 6119751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
    Sorbi C; Franchini S; Tait A; Prandi A; Gallesi R; Angeli P; Marucci G; Pirona L; Poggesi E; Brasili L
    ChemMedChem; 2009 Mar; 4(3):393-9. PubMed ID: 19152363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor interaction for the alpha-antagonist WB4101 (2(N[2,6-dimethyoxyphenoxyethyl])amino-methyl-1,4-benzodioxane).
    Kapur H; Mottram DR; Green PN
    J Pharm Pharmacol; 1978 Apr; 30(4):259-60. PubMed ID: 24721
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha 1- and alpha 2-adrenoceptors: pharmacology and clinical implications.
    Starke K; Docherty JR
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S14-23. PubMed ID: 6169956
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacology and clinical application of alpha-blocking drugs (author's transl)].
    Weber S; Merillon JP; Motte G; Gourgon R
    Therapie; 1980; 35(6):665-76. PubMed ID: 6112802
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional study of the excitatory alpha-adrenoceptor in guinea pig ileum, in relation to the hypothesis of an atypical receptor.
    Bricola A; Jurkiewicz NH; Jurkiewicz A
    Ann N Y Acad Sci; 1997 May; 812():189-92. PubMed ID: 9186739
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of 3H-clonidine to an alpha-adrenoceptor in membranes of guinea-pig ileum.
    Tanaka T; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):207-15. PubMed ID: 43474
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.
    McDevitt DG
    Drugs; 1979 Apr; 17(4):267-88. PubMed ID: 37065
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of terazosin: an alpha 1-selective blocker.
    Kyncl JJ
    J Clin Pharmacol; 1993 Sep; 33(9):878-83. PubMed ID: 7901242
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro studies with (imidazolinyl-2)-2-benzodioxane-1-4 ((+/-)-170 150), a new potent alpha 2-adrenoceptor blocking agent.
    Dabiré H; Dausse JP; Mouillé P; Schmitt H; Meyer P
    Eur J Pharmacol; 1982 Dec; 86(1):87-90. PubMed ID: 6130957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclassification and nomenclature of alpha- and beta-adrenoceptors.
    Hieble JP
    Curr Top Med Chem; 2007; 7(2):129-34. PubMed ID: 17266601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.